Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study
Phosphodiesterase type 5 (PDE 5) inhibitors are currently first-line medical treatment for erectile dysfunction (ED). PDE 5 inhibitors are differentiated by safety-tolerability profiles and efficacy considerations, such as time to onset and duration of action. The choice of PDE 5 inhibitors in a ma...
Main Author: | Emre Bakırcıoğlu |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2015-09-01
|
Series: | Journal of Urological Surgery |
Online Access: | http://jurolsurgery.org/article_9805/Efficacy-Of-Avanafil-15-Minutes-After-Dosing-In-Men-With-Erectile-Dysfunction-A-Randomized-Double-blind-Placebo-Controlled-Study |
Similar Items
-
Efficacy and Safety of Avanafil in Chinese Subjects With Erectile Dysfunction: A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Phase III Clinical Trial
by: Hui Jiang, MD, PhD, et al.
Published: (2021-06-01) -
Future prospects in the treatment of erectile dysfunction: focus on avanafil
by: Alwaal A, et al.
Published: (2011-10-01) -
Avanafil for treatment of erectile dysfunction: review of its potential
by: Burke RM, et al.
Published: (2012-08-01) -
Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties
by: George T. Kedia, et al.
Published: (2013-02-01) -
Avanafil for male erectile dysfunction: a systematic review and meta-analysis
by: Yuan-Shan Cui, et al.
Published: (2014-06-01)